According to New York State Vital Statistics, in 2001 in-home chemical abortion represented just three out of every one hundred abortions. Now, chemical abortion represents one out of every three in New York. Nationwide it is estimated that chemical abortion accounts for nearly 50% of all abortion. The trend is gaining speed. Whether due to increased abortion restrictions driving up demand for the pills, increasing social and financial life-pressures, or COVID normalizing in-home telemedicine, the movement away from surgical to in-home chemical abortion poses a four hundred percent increased risk to women, under supervision of a physician. The risks are even higher if women purchase and consume abortion drugs illicitly from off-shore suppliers or outside the FDA protocols for physician care. Is the abortion industry motivated by women’s health or by profiting from a woman’s crisis?